Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Novel Adjuvants for Peptide-Based Melanoma Vaccines

This study has been completed.
Information provided by (Responsible Party):
University of Southern California Identifier:
First received: January 4, 2002
Last updated: May 20, 2014
Last verified: May 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2005
  Primary Completion Date: January 2003 (Final data collection date for primary outcome measure)